Zhao H, Xu C, Luo X, Wei F, Wang N, Shi H
Front Immunol. 2018; 9:335.
PMID: 29563911
PMC: 5845880.
DOI: 10.3389/fimmu.2018.00335.
Revaud J, Unterfinger Y, Rol N, Suleman M, Shaw J, Galea S
Front Cell Infect Microbiol. 2018; 8:6.
PMID: 29423380
PMC: 5788964.
DOI: 10.3389/fcimb.2018.00006.
Shim B, Stadler K, Nguyen H, Yun C, Kim D, Chang J
Virol J. 2012; 9:215.
PMID: 22995185
PMC: 3489719.
DOI: 10.1186/1743-422X-9-215.
Zhou D, Zhou X, Bian A, Li H, Chen H, Small J
Nat Protoc. 2010; 5(11):1775-1785.
PMID: 21030953
PMC: 3994680.
DOI: 10.1038/nprot.2010.134.
Ertl H
PLoS Negl Trop Dis. 2009; 3(9):e515.
PMID: 19787033
PMC: 2742899.
DOI: 10.1371/journal.pntd.0000515.
Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.
Croyle M, Patel A, Tran K, Gray M, Zhang Y, Strong J
PLoS One. 2008; 3(10):e3548.
PMID: 18958172
PMC: 2569416.
DOI: 10.1371/journal.pone.0003548.
Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.
Olson M, Varga S
Expert Rev Vaccines. 2008; 7(8):1239-55.
PMID: 18844597
PMC: 2630464.
DOI: 10.1586/14760584.7.8.1239.
Genetic medicine strategies to protect against bioterrorism.
Boyer J, Crystal R
Trans Am Clin Climatol Assoc. 2008; 117:297-310.
PMID: 18528482
PMC: 1500914.
Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection.
Yu J, Kim S, Lee J, Chang J
J Virol. 2007; 82(5):2350-7.
PMID: 18094185
PMC: 2258907.
DOI: 10.1128/JVI.02372-07.
Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin.
Okamba F, Moreau E, Cheikh Saad Bouh K, Gagnon C, Massie B, Arella M
Clin Vaccine Immunol. 2007; 14(6):767-74.
PMID: 17409219
PMC: 1951074.
DOI: 10.1128/CVI.00415-06.
Intramuscular rather than oral administration of replication-defective adenoviral vaccine vector induces specific CD8+ T cell responses in the gut.
Lin S, Cun A, Harris-McCoy K, Ertl H
Vaccine. 2007; 25(12):2187-93.
PMID: 17229501
PMC: 1839821.
DOI: 10.1016/j.vaccine.2006.11.044.
Development of nonhuman adenoviruses as vaccine vectors.
Bangari D, Mittal S
Vaccine. 2005; 24(7):849-62.
PMID: 16297508
PMC: 1462960.
DOI: 10.1016/j.vaccine.2005.08.101.
Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.
Hashimoto M, Boyer J, Hackett N, Wilson J, Crystal R
Infect Immun. 2005; 73(10):6885-91.
PMID: 16177368
PMC: 1230977.
DOI: 10.1128/IAI.73.10.6885-6891.2005.
Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
Zhi Y, Kobinger G, Jordan H, Suchma K, Weiss S, Shen H
Virology. 2005; 335(1):34-45.
PMID: 15823604
PMC: 7111773.
DOI: 10.1016/j.virol.2005.01.050.
Adenoviruses as vaccine vectors.
Tatsis N, Ertl H
Mol Ther. 2004; 10(4):616-29.
PMID: 15451446
PMC: 7106330.
DOI: 10.1016/j.ymthe.2004.07.013.
Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.
Capozzo A, Cuberos L, Levine M, Pasetti M
Infect Immun. 2004; 72(8):4637-46.
PMID: 15271924
PMC: 470595.
DOI: 10.1128/IAI.72.8.4637-4646.2004.